Pushing the Limits of Prostate Cancer Diagnosis and Characterization through an AI-based Tools Webinar

Published on: February 5, 2024
Categories: News

Artificial intelligence (AI) technologies could significantly improve the diagnosis of prostate cancer, early results from a new European Commission-funded research project show. Presenting findings at a Europa Uomo webinar, the team from the ProCAncer-I project reported that it was validating promising new AI models for detecting lesions and predicting aggressiveness.

“We believe that the project is about to deliver some significant results, once some of these models are clinically validated within the next 12-14 months,” said Manolis Tsiknakis, ProCAncer-I Coordinator.

ProCAncer-I brings together 20 partners from 11 countries, including 13 prostate cancer reference centres, centres of technical excellence and world leaders in AI. With a budget of €10 million, it is collecting a unique database of tens of thousands of real life case studies, with accompanying mpMRI images. The database already includes seven million images. Researchers are using the database to see whether artificial intelligence tools can accurately characterise lesions, assess metastatic potential, detect recurrence early and stratify patients for active surveillance.

Speaking at the Europa Uomo AI webinar, Nikolaos Papanikolaou, Scientific Manager of ProCAncer-I, said that results were so far very promising in terms of detecting lesions and predicting aggressiveness. “We have very positive results in the field of detection and characterisation of prostate cancer, aggressiveness mainly, while we have encouraging results for all the other clinical use cases,” he said. To learn more about the use of artificial intelligence in the diagnosis and treatment of prostate cancer, watch the video of the Europa Uomo webinar below or on YouTube.

Highlights

Third Dissemination Event of the ProCAncer-I Project in Athens

Third Dissemination Event of the ProCAncer-I Project in Athens

ProCAncer-I will be organising the 3rd Dissemination Event at the 21st IEEE International Symposium on Biomedical Imaging, which will be held in Athens, Greece, May 27-30, 2024. ProCAncer-I will organise the Workshop “Integrating imaging Data and AI models for...

ProCAncer-I at the ECR 2024 in Vienna

ProCAncer-I at the ECR 2024 in Vienna

A great congress once more! Artificial Intelligence (AI) took the spotlight at the European Radiology Congress (ECR) held at the Austria Center Vienna from February 28 to March 3. Under the theme of 'Next Generation Radiology,' cutting-edge technologies were...

Stay in touch!